Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Am Coll Surg. 2015 May 18;221(3):643–785. doi: 10.1016/j.jamcollsurg.2015.05.007

Table 2.

Baseline characteristics for 194 patients with Stage I and II colon cancer

Variable pN0i− pN0i+ p Value Total
n % n % n %
Recurred <0.001
 Missing 0 0.0 1 2.38 1 0.52
 No 148 97.4 34 80.9 182 93.8
 Yes 4 2.6 7 16.7 11 5.67
Died 0 0.0 1 2.38 <0.001 1 0.51
 No 147 96.7 30 71.4 177 91.2
 Yes 5 3.3 11 26.2 16 8.3
Status <0.001
 Unknown 0 0.0 1 2.4 1 0.5
 AWD 3 2.0 1 2.4 4 2.1
 DOC 4 2.63 6 14.3 10 51.5
 DOD 1 0.7 5 11.9 6 3.1
 NED 144 94.7 29 69.0 173 89.2

pN0i−, pathologically node negative and negative pancytokeratin immunohistochemistry; pN0i+, single or small clusters of distinct tumor cells < 0.2 mm identified by immunohistochemistry or molecular staging; AWD, alive with disease; DOC, died of unrelated causes; DOD, dead of disease; NED, no evidence of disease.